Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 153

1.

Cognitive function during neoadjuvant chemotherapy for breast cancer: results of a prospective, multicenter, longitudinal study.

Hermelink K, Untch M, Lux MP, Kreienberg R, Beck T, Bauerfeind I, Münzel K.

Cancer. 2007 May 1;109(9):1905-13.

2.

Short-term effects of treatment-induced hormonal changes on cognitive function in breast cancer patients: results of a multicenter, prospective, longitudinal study.

Hermelink K, Henschel V, Untch M, Bauerfeind I, Lux MP, Munzel K.

Cancer. 2008 Nov 1;113(9):2431-9. doi: 10.1002/cncr.23853.

3.
4.

A prospective longitudinal study of chemotherapy-induced cognitive changes in breast cancer patients.

Jansen CE, Cooper BA, Dodd MJ, Miaskowski CA.

Support Care Cancer. 2011 Oct;19(10):1647-56. doi: 10.1007/s00520-010-0997-4. Epub 2010 Sep 5.

PMID:
20820813
5.

Objective and self-reported cognitive dysfunction in breast cancer women treated with chemotherapy: a prospective study.

Biglia N, Bounous VE, Malabaila A, Palmisano D, Torta DM, D'Alonzo M, Sismondi P, Torta R.

Eur J Cancer Care (Engl). 2012 Jul;21(4):485-92. doi: 10.1111/j.1365-2354.2011.01320.x. Epub 2011 Dec 28.

PMID:
22211832
6.

Preliminary results of a longitudinal study of changes in cognitive function in breast cancer patients undergoing chemotherapy with doxorubicin and cyclophosphamide.

Jansen CE, Dodd MJ, Miaskowski CA, Dowling GA, Kramer J.

Psychooncology. 2008 Dec;17(12):1189-95. doi: 10.1002/pon.1342.

PMID:
18506671
7.

Two different sides of 'chemobrain': determinants and nondeterminants of self-perceived cognitive dysfunction in a prospective, randomized, multicenter study.

Hermelink K, Küchenhoff H, Untch M, Bauerfeind I, Lux MP, Bühner M, Manitz J, Fensterer V, Münzel K.

Psychooncology. 2010 Dec;19(12):1321-8. doi: 10.1002/pon.1695.

PMID:
20127909
8.

Cognitive effects of chemotherapy-induced menopause in breast cancer.

Vearncombe KJ, Rolfe M, Andrew B, Pachana NA, Wright M, Beadle G.

Clin Neuropsychol. 2011 Nov;25(8):1295-313. doi: 10.1080/13854046.2011.631586. Epub 2011 Nov 2.

PMID:
22047059
9.

Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma.

Schagen SB, van Dam FS, Muller MJ, Boogerd W, Lindeboom J, Bruning PF.

Cancer. 1999 Feb 1;85(3):640-50.

PMID:
10091737
10.

Neurophysiological evaluation of late effects of adjuvant high-dose chemotherapy on cognitive function.

Schagen SB, Hamburger HL, Muller MJ, Boogerd W, van Dam FS.

J Neurooncol. 2001 Jan;51(2):159-65.

PMID:
11386413
11.

Neuropsychological performance in survivors of breast cancer more than 20 years after adjuvant chemotherapy.

Koppelmans V, Breteler MM, Boogerd W, Seynaeve C, Gundy C, Schagen SB.

J Clin Oncol. 2012 Apr 1;30(10):1080-6. doi: 10.1200/JCO.2011.37.0189. Epub 2012 Feb 27.

PMID:
22370315
12.

Change in cognitive function after chemotherapy: a prospective longitudinal study in breast cancer patients.

Schagen SB, Muller MJ, Boogerd W, Mellenbergh GJ, van Dam FS.

J Natl Cancer Inst. 2006 Dec 6;98(23):1742-5.

PMID:
17148777
13.

Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: high-dose versus standard-dose chemotherapy.

van Dam FS, Schagen SB, Muller MJ, Boogerd W, vd Wall E, Droogleever Fortuyn ME, Rodenhuis S.

J Natl Cancer Inst. 1998 Feb 4;90(3):210-8.

PMID:
9462678
14.

Fatigue, menopausal symptoms, and cognitive function in women after adjuvant chemotherapy for breast cancer: 1- and 2-year follow-up of a prospective controlled study.

Fan HG, Houédé-Tchen N, Yi QL, Chemerynsky I, Downie FP, Sabate K, Tannock IF.

J Clin Oncol. 2005 Nov 1;23(31):8025-32.

PMID:
16258100
15.

No indications of cognitive side-effects in a prospective study of breast cancer patients receiving adjuvant chemotherapy.

Mehlsen M, Pedersen AD, Jensen AB, Zachariae R.

Psychooncology. 2009 Mar;18(3):248-57. doi: 10.1002/pon.1398.

PMID:
18756583
16.

The nature and severity of cognitive impairment associated with adjuvant chemotherapy in women with breast cancer: a meta-analysis of the current literature.

Falleti MG, Sanfilippo A, Maruff P, Weih L, Phillips KA.

Brain Cogn. 2005 Oct;59(1):60-70. Epub 2005 Jun 21. Review.

PMID:
15975700
17.

Cognitive effects of chemotherapy in post-menopausal breast cancer patients 1 year after treatment.

Collins B, Mackenzie J, Stewart A, Bielajew C, Verma S.

Psychooncology. 2009 Feb;18(2):134-43. doi: 10.1002/pon.1379.

PMID:
18551510
18.

Acute and late onset cognitive dysfunction associated with chemotherapy in women with breast cancer.

Wefel JS, Saleeba AK, Buzdar AU, Meyers CA.

Cancer. 2010 Jul 15;116(14):3348-56. doi: 10.1002/cncr.25098.

19.

Cognitive function, fatigue, and menopausal symptoms in women receiving adjuvant chemotherapy for breast cancer.

Tchen N, Juffs HG, Downie FP, Yi QL, Hu H, Chemerynsky I, Clemons M, Crump M, Goss PE, Warr D, Tweedale ME, Tannock IF.

J Clin Oncol. 2003 Nov 15;21(22):4175-83.

PMID:
14615445
20.

Feasibility of quantifying the effects of epoetin alfa therapy on cognitive function in women with breast cancer undergoing adjuvant or neoadjuvant chemotherapy.

O'Shaughnessy JA, Vukelja SJ, Holmes FA, Savin M, Jones M, Royall D, George M, Von Hoff D.

Clin Breast Cancer. 2005 Feb;5(6):439-46.

PMID:
15748464

Supplemental Content

Support Center